NKTX
NKTX
NASDAQ · Biotechnology

Nkarta Inc

$2.02
+0.10 (+5.21%)
As of Feb 8, 2:08 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 19.33M 18.18M 17.68M
Net Income -947,103 -802,247 -886,084
EPS
Profit Margin -4.9% -4.4% -5.0%
Rev Growth +21.0% +13.7% -3.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 28.23M 29.20M 25.01M
Total Equity 79.20M 66.12M 75.56M
D/E Ratio 0.36 0.44 0.33
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,287,077 -1,124,832 -1,061,399
Free Cash Flow -739,760 -479,993 -441,081